From Bench to Bedside Faster, Safer, and with Fewer Surprises.
Nucelion is a next-generation Cell & Gene Therapy CDMO helping innovators accelerate their journey from discovery to clinical impact. With deep expertise in viral vectors (AAV, Lentivirus) and cell therapies (CAR-T, NK, iPSC-derived), we bring scientific precision and operational discipline under one roof.
Dr. Raghu Malapaka
CBO –Nucelion Therapeutics
Raghu Malapaka, Ph.D, CBO, Nucelion. Dr. Raghu Malapaka has an extensive commercial experience in the development and manufacturing of large molecules as well as advanced therapies. He served in leadership roles in global CDMOs including AGC Bio, Thermofisher and WuXi and played key role in bringing some of the earliest CGTs to the patients. He has a PhD in molecular biology and post-doctoral experience at Harvard Medical School.
Where We Operate
We’re headquartered in Genome Valley, Hyderabad, India, with GMP manufacturing, QC, and development labs under one roof.
Our location within India’s premier biotech hub provides access to world-class scientific talent, infrastructure, and collaboration opportunities that drive every program forward.
We partner with hospitals, biotech startups, and pharmaceutical companies that value responsiveness, precision, and accountability.
We do not oversell capacity — what we promise, we deliver.
Our Mission
Bring world-class CGT manufacturing within reach — technically rigorous, ethically responsible, and economically sane.


